中文 | English
Return
Total: 390 , 1/39
Show Home Prev Next End page: GO
MeSH:(Trans-Activators)

1.Inhibition of HIV-1 in vitro by combination of vpr and tat specific short hairpin RNA via lentiviral vectors.

Yan-Zhe HAO ; Zhi-Ping TENG ; Yi-Shu YANG ; Xiao-Na SUN ; Jing MA ; Xiao-Hua JIN ; Yi ZENG

Chinese Journal of Virology 2013;29(2):126-131

3.Expression and purification of TAT-HBX-EGFP fusion protein and its transmembrane distribution in mouse.

Ying SHI ; Fei-Li WEI ; Ya-Li LIU ; Yun-Xia JI ; Hao WU ; De-Xi CHEN ; Yu-Sen ZHOU

Chinese Journal of Experimental and Clinical Virology 2008;22(4):287-289

4.Hepatitis B virus X protein suppressing adriamycin-induced apoptosis of HepG2 cells.

Hong-mei FAN ; Lin YANG ; Qi-feng XIE ; Xiao-yan HAN ; Meng WU ; Fu-cheng ZHANG ; Chun-lan YAO ; Gang LI ; Zhi-liang GAO

Chinese Journal of Hepatology 2008;16(1):25-28

5.Effects of trichostatin A on the interaction between HBx and histone deacetylase protein 1.

Ju-qiang HAN ; Qi-nong YE ; Li-Hua DING ; Jie-zhi LI ; Xiao YANG ; Cui-fen HUANG

Chinese Journal of Hepatology 2008;16(9):657-659

7.Cloning of genes transactivated by hepatitis B virus X protein.

Yan LIU ; Jun CHENG ; Yin-ying LU ; Gang WANG ; Jing-shong MOU ; Li LI ; Ling-xia ZHANG ; Ju-mei CHEN

Chinese Journal of Hepatology 2003;11(1):5-7

8.High yields and soluble expression of superoxide dismutases in Escherichia coli due to the HIV-1 Tat peptide via increases in mRNA transcription.

Yangdong SUN ; Qiao YE ; Min WU ; Yonghong WU ; Chenggang ZHANG ; Weiqun YAN

Experimental & Molecular Medicine 2016;48(10):e264-

9.Enhanced CEA-specific Immune Responses by Tat-LLO Fusion Protein.

Soon Aei YI ; Hyun Jung SOHN ; Chang Hyun KIM ; Mi Young PARK ; Seong Taek OH ; Tai Gyu KIM

Immune Network 2005;5(3):172-178

10.Advances in transcription activator-like effectors--a review.

Tang YU ; Lisha LI ; Jun LIN

Chinese Journal of Biotechnology 2015;31(7):1024-1038

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 390 , 1/39 Show Home Prev Next End page: GO